Substance
ID:355677
Names and Identifiers
IUPAC name
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one dihydrate
Synonyms
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate2-(3,4-二羟苯基)-3,5,7-三羟基-4H-1-苯并吡喃-4-酮 二水合物3,3′,4′,5,7-五羟基黄酮 二水合物Quercetin dihydrate槲皮素 二水合物3,3′,4′,5,7-Pentahydroxyflavone dihydrate
IUPAC Traditional name
quercetin dihydrate
Registration numbers
CAS Number
MDL Number
Beilstein Number
EC Number
Color Index Number
Properties
Safety Information
European Hazard Symbols
Toxic (T)GHS Precautionary statements
P301+P310
RTECS
LK8950000
MSDS Link
Risk Statements
25
GHS Hazard statements
H301
German water hazard class
3
Safety Statements
45
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), categories 1,2,3
GHS Signal Word
Danger
Product Information
Grade
primary reference standard
Empirical Formula (Hill Notation)
C15H10O7 · 2H2O
Physical Property
Melting Point
>300 °C(lit.)
Molecule Details
Application
Reference standard in the analysis of herbal medicinal products.
General description
Produced and qualified by HWI AnalytikExact content by quantitative NMR can be found on the certificate
Biochem/physiol Actions
Quercetin dihydrate is a flavonoid with anticancer activity. Quercetin is a mitochondrial ATPase and phosphodiesterase inhibitor. It Inhibits PI3-kinase activity and slightly inhibits PIP kinase activity. Quercetin has antiproliferative effects on cancer cell lines, reduces cancer cell growth via type II estrogen receptors, and arrests human leukemic T cells in late G1 phase of the cell cycle.
Reference standard in the analysis of herbal medicinal products.
General description
Produced and qualified by HWI AnalytikExact content by quantitative NMR can be found on the certificate
Biochem/physiol Actions
Quercetin dihydrate is a flavonoid with anticancer activity. Quercetin is a mitochondrial ATPase and phosphodiesterase inhibitor. It Inhibits PI3-kinase activity and slightly inhibits PIP kinase activity. Quercetin has antiproliferative effects on cancer cell lines, reduces cancer cell growth via type II estrogen receptors, and arrests human leukemic T cells in late G1 phase of the cell cycle.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data